| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 42.888 | 70.587 | 28.753 | 27.149 |
| Total Income - EUR | - | - | - | - | - | - | 101.767 | 128.484 | 84.156 | 79.356 |
| Total Expenses - EUR | - | - | - | - | - | - | 50.412 | 76.612 | 108.255 | 108.994 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 51.356 | 51.872 | -24.099 | -29.638 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 50.069 | 49.755 | -24.418 | -29.638 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Bio-Benning S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 75.972 | 102.209 | 114.307 | 93.039 |
| Inventories | - | - | - | - | - | - | 36.091 | 49.093 | 28.024 | 5.312 |
| Receivables | - | - | - | - | - | - | 5.051 | 21.690 | 29.195 | 51.814 |
| Cash | - | - | - | - | - | - | 34.829 | 31.427 | 57.088 | 35.914 |
| Shareholders Funds | - | - | - | - | - | - | 50.271 | 100.182 | 75.460 | 46.491 |
| Social Capital | - | - | - | - | - | - | 202 | 203 | 202 | 201 |
| Debts | - | - | - | - | - | - | 25.701 | 2.028 | 38.847 | 46.548 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Bio-Benning S.r.l.